Research Projects
New biomarkers for personalized lung cancer risk assessment in low-dose CT screening protocols: development and validation of highly sensitive protein signatures in combination with radiomic analysis
Researcher | Principal Investigator
Research Group Lungsearch: Lung cancer Screening, Early detection, biomarkers and new therapeutic targets
Research Division
Cancer Division
Research program
Solid Tumors
Project information
Research project called New biomarkers for personalized lung cancer risk assessment in low-dose CT screening protocols: development and validation of highly sensitive protein signatures in combination with radiomic analysis belonging to the Biomarkers and New Therapeutic Targets in Lung Cancer Group of the Cima University of Navarra.
- Convocation: LUNG AMBITION ALLIANCE
- Start date: October 27, 2021
- End date: October 26, 2024
- Funder: Astra Zeneca Farmacéutica Spain, S.A.
- Nature of project: National
- Award year 2021
Need more information?
If you are interested in learning more about our research, please contact us.